Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 5Recruiting 5Withdrawn 4Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1Breast 1

Conditions

Small Cell Lung Carcinoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Thymalfasin × Clear all
NCT02535988 2023-09-21

Abscopal Effect for Metastatic Colorectal Cancer

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Gastrointestinal

Colorectal Neoplasms

NCT02542930 2019-03-26

Abscopal Effect for Metastatic Non-small Cell Lung Cancer.

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02542137 2019-03-21

Abscopal Effect for Metastatic Small Cell Lung Cancer

Zhejiang Provincial People's Hospital

Phase 2 Withdrawn
Thoracic

Small Cell Lung Carcinoma

NCT00935558 2012-05-31

Dendritic Cell Based Therapy for Breast Cancer Patients

Herlev Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡